Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/Conditions /Clinical Trials for Bladder Problems After Spinal Cord Injury
Updated July 2026

Clinical Trials for Bladder Problems After Spinal Cord Injury

Neurogenic bladder and urinary incontinence following spinal cord injury — what studies are looking for.

Actively enrolling

Studies currently enrolling

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for bladder problems after spinal cord injury

This study is enrolling adults in the United States who have been diagnosed with urinary incontinence caused by a spinal cord injury. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Bladder dysfunction after a spinal cord injury is close to universal, and it is consistently ranked by people living with SCI as one of the changes with the greatest effect on daily life. The clinical term is neurogenic bladder: the nerve signalling between bladder and brain is disrupted, and normal control is lost.

Studies are enrolling US adults diagnosed with urinary incontinence caused by a spinal cord injury. This page covers what that means in practice for eligibility, and how to find what is recruiting near you.

Who studies are looking for

The criterion is specific: urinary incontinence caused by a spinal cord injury. Both halves matter. Incontinence from other causes — age-related, post-surgical, post-partum — is a different research area with its own studies. And an SCI without bladder involvement is not what these protocols are recruiting for.

Beyond that, individual protocols vary in what they require: level and completeness of injury, time elapsed since injury, current bladder management method (intermittent catheterisation, indwelling catheter, reflex voiding), and what treatments have already been tried. Those details are worked through on the screening call rather than on the form.

Because SCI is a comparatively small population, recruitment tends to be national rather than concentrated in a few sites, and studies often accept participants across a wide travel radius.

Why bladder function is a research priority

Surveys of people living with spinal cord injury consistently place bladder and bowel function among the highest recovery priorities — in several studies rated above walking. That reflects how much daily routine, autonomy and health risk are bound up in it.

The health stakes are real too: neurogenic bladder carries elevated risk of recurrent urinary tract infections and, over the long term, kidney damage if pressures are not managed. Research in this area is aimed both at continence and at protecting the upper urinary tract.

Clinical research laboratory

What screening involves

An initial form confirms the SCI-related incontinence diagnosis. A coordinator then calls to go through injury history, current bladder management, medications and prior treatments. If a protocol looks like a fit, an in-person assessment follows — often including urodynamic testing, which measures bladder pressure and capacity.

Accessibility is a fair question to raise early. Research sites recruiting for SCI studies are generally set up for wheelchair access and accessible transport, and many reimburse travel costs, but confirming specifics for your situation on the first call is sensible.

Screening is free, and compensation for time and travel is set by each protocol and disclosed in writing before enrollment. US studies generally pay $75 to $4,500 per completed study depending on visit count and procedures.

Want to know when a paid study opens near you?

Join the free email alert — we watch the NIH registry weekly so you don't have to.

Get trial alerts

The terms you will see on listings

Registry listings use clinical language that is worth being able to parse:

  • Neurogenic bladder / neurogenic detrusor overactivity — bladder dysfunction from disrupted nerve signalling; the detrusor is the bladder wall muscle.
  • Urinary incontinence — involuntary loss of urine.
  • Intermittent catheterisation — periodic catheter emptying, the most common management method after SCI.
  • Urodynamics — the test measuring bladder pressure, capacity and flow, common at study screening.

Searching several of these terms is worthwhile when looking through registry listings, since studies index under whichever the sponsor chose.

Frequently asked questions

Does my injury level affect eligibility?

It can. Some protocols specify injury level or completeness, others do not. Since it varies by study, the screening call is where it gets established — the initial form generally only checks that the incontinence is SCI-related.

I use intermittent catheterisation. Can I still take part?

Often yes. Intermittent catheterisation is the most common bladder management method after spinal cord injury, and protocols are usually designed around that reality. Some studies specify a particular management method as a criterion, so it is asked about early.

Does incontinence from another cause qualify?

Not for these studies. The criterion is specifically urinary incontinence caused by a spinal cord injury. Incontinence from other causes is researched separately, with its own enrolling studies.

Are research sites accessible?

Sites recruiting for spinal cord injury studies are generally equipped for wheelchair access, and many reimburse accessible transport costs. Specifics vary by site, so it is worth confirming what you need on the first call with the coordinator.

Where studies for this condition are recruiting

Enrolling across the United States — the largest metros are listed first

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts